• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION ENVEO R DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION ENVEO R DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number ENVEOR-L
Device Problem Fracture (1260)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/02/2017
Event Type  malfunction  
Manufacturer Narrative
Product analysis: the product has not been returned for analysis, therefore no product analysis can be performed.Conclusion: capsule separation typically occurs due to excessive compressive forces applied during the valve loading, tracking, and/or deployment process.This excessive compressive force is typically experienced when the valve is loaded incorrectly.In this case, it was reported that the valve was noticed to have been initially misloaded (curved capsule), but was reportedly straightened out prior to introduction into the patient.It was also reported that a misload was detected upon review of imaging following the procedure.As no fluoroscopic load check images were submitted for review, it cannot be independently determined if the valve was correctly loaded onto the delivery catheter system (dcs).The subject device was not returned for evaluation, but images were provided showing the capsule damage outside of the patient.The lot history review was performed on the device; there were no correlations / issues identified regarding manufacturing.The device was manufactured per approved and released manufacturing processes and the device met all applicable manufacturing specifications prior to release for distribution.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that prior to the implant of a 26 mm transcatheter bioprosthetic valve, it was noted by hospital staff that the capsule was curved at the end of loading.Tension was removed and the capsule no longer appeared curved.No misload was detected at the time and the operators proceeded with the procedure using right femoral artery access.At the beginning of valve deployment, the capsule was noted to be broken.It was reported that there was no unusual tension felt in the system and the capsule did not completely separate.The valve was recaptured and removed from the patient without consequence.A different delivery catheter system was used to successfully complete the procedure.Upon review of angiography by following the procedure, a misload was identified with the delivery catheter system.No adverse patient effects were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.The subject device was not returned for evaluation, but images submitted for review also confirm separation of the capsule during deployment.Capsule separation typically occurs due to excessive compressive forces applied during valve loading, tracking, and/or deployment process.This excessive compressive force is typically experienced when the valve is loaded incorrectly.Fluoroscopic images submitted for review confirmed a misloaded valve due to a bent capsule and misaligned paddles.Loading of the valve is a process highly dependent on the operator technique.The device instructions for use (ifu) contains instructions to use the integrated loading bath which features a mirror to aid in accurate placement of the transcatheter aortic valve (tav) frame paddles during loading.The user is instructed to not advance the capsule over the frame paddles unless they are fully seated in the center of the paddle pockets, and to perform an inspection of the loaded capsule under fluoroscopy.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENVEO R DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key7248588
MDR Text Key99245413
Report Number2025587-2018-00322
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/30/2017
Device Model NumberENVEOR-L
Device Catalogue NumberENVEOR-L
Device Lot Number0008199565
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/11/2018
Initial Date FDA Received02/07/2018
Supplement Dates Manufacturer Received02/15/2018
09/26/2018
Supplement Dates FDA Received02/15/2018
10/17/2018
Date Device Manufactured08/30/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-